GeoWealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-413
Closed -$17.2K 1529
2024
Q4
$17.2K Sell
413
-201
-33% -$9.61K ﹤0.01% 1406
2024
Q3
$41K Sell
614
-708
-54% -$65K ﹤0.01% 1130
2024
Q2
$157K Sell
1,322
-52
-4% -$6.58K 0.01% 733
2024
Q1
$146K Buy
+1,374
New +$138K 0.01% 738

Other funds holding MRNA

GeoWealth Management's MRNA Position: Q1 2025 in Review

GeoWealth Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 413 shares — an estimated $17.2K sold.

GeoWealth Management first reported a position in MRNA in Q1 2024 and held it in 4 quarters. The position peaked at $157K in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • GeoWealth Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • GeoWealth Management sold 413 Moderna shares in Q1 2025, an estimated $17.2K.
  • GeoWealth Management first reported a position in Moderna in Q1 2024 and held it in 4 quarters.
  • GeoWealth Management's Moderna position peaked at $157K in Q2 2024.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on GeoWealth Management's 13F filing for Q1 2025, filed 9 May 2025.